Adirondack Research & Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $502K | Sell |
8,133
-330
| -4% | -$19.9K | 0.61% | 70 |
|
|
2021
Q2 | $507K | Sell |
8,463
-365
| -4% | -$23.1K | 0.59% | 68 |
|
|
2021
Q1 | $537K | Sell |
8,828
-10
| -0.1% | -$552 | 0.63% | 62 |
|
|
2020
Q4 | $415K | Hold |
8,838
| – | – | 0.57% | 57 |
|
|
2020
Q3 | $329K | Buy |
8,838
+15
| +0.2% | +$569 | 0.46% | 59 |
|
|
2020
Q2 | $322K | Sell |
8,823
-130
| -1% | -$4.53K | 0.42% | 56 |
|
|
2020
Q1 | $274K | Buy |
8,953
+200
| +2% | +$8.87K | 0.38% | 64 |
|
|
2019
Q4 | $446K | Hold |
8,753
| – | – | 0.39% | 61 |
|
|
2019
Q3 | $413K | Sell |
8,753
-200
| -2% | -$9.54K | 0.36% | 69 |
|
|
2019
Q2 | $445K | Hold |
8,953
| – | – | 0.32% | 69 |
|
|
2019
Q1 | $381K | Sell |
8,953
-350
| -4% | -$15.5K | 0.24% | 82 |
|
|
2018
Q4 | $382K | Hold |
9,303
| – | – | 0.24% | 80 |
|
|
2018
Q3 | $435K | Hold |
9,303
| – | – | 0.16% | 95 |
|
|
2018
Q2 | $426K | Sell |
9,303
-417
| -4% | -$19.4K | 0.17% | 90 |
|
|
2018
Q1 | $446K | Sell |
9,720
-2,630
| -21% | -$128K | 0.18% | 91 |
|
|
2017
Q4 | $624K | Sell |
12,350
-50
| -0.4% | -$2.63K | 0.25% | 74 |
|
|
2017
Q3 | $644K | Sell |
12,400
-1,513
| -11% | -$73.7K | 0.25% | 71 |
|
|
2017
Q2 | $681K | Buy |
13,913
+337
| +2% | +$15.6K | 0.27% | 69 |
|
|
2017
Q1 | $639K | Hold |
13,576
| – | – | 0.23% | 74 |
|
|
2016
Q4 | $652K | Buy |
13,576
+112
| +0.8% | +$5.14K | 0.22% | 73 |
|
|
2016
Q3 | $533K | Hold |
13,464
| – | – | 0.19% | 78 |
|
|
2016
Q2 | $478K | Buy |
13,464
+224
| +2% | +$8.74K | 0.18% | 79 |
|
|
2016
Q1 | $518K | Buy |
13,240
+225
| +2% | +$8.41K | 0.19% | 80 |
|
|
2015
Q4 | $559K | Hold |
13,015
| – | – | 0.2% | 76 |
|
|
2015
Q3 | $547K | Hold |
13,015
| – | – | 0.21% | 79 |
|
|
2015
Q2 | $649K | Hold |
13,015
| – | – | 0.24% | 72 |
|
|
2015
Q1 | $586K | Buy |
13,015
+112
| +0.9% | +$5.03K | 0.23% | 75 |
|
|
2014
Q4 | $622K | Hold |
12,903
| – | – | 0.23% | 76 |
|
|
2014
Q3 | $618K | Hold |
12,903
| – | – | 0.23% | 78 |
|
|
2014
Q2 | $639K | Sell |
12,903
-337
| -3% | -$15.8K | 0.22% | 81 |
|
|
2014
Q1 | $623K | Hold |
13,240
| – | – | 0.24% | 80 |
|
|
2013
Q4 | $636K | Sell |
13,240
-224
| -2% | -$10K | 0.31% | 75 |
|
|
2013
Q3 | $563K | Sell |
13,464
-224
| -2% | -$9.65K | 0.32% | 77 |
|
|
2013
Q2 | $558K | Buy |
+13,688
| New | +$503K | 0.42% | 73 |
|
Other funds holding MET
Adirondack Research & Management's MET Position: Q3 2021 in Review
Adirondack Research & Management reduced its MetLife (MET) stake by 3.9% in Q3 2021, selling an estimated $19.9K and leaving 8,133 shares worth $502K. The position accounts for 0.61% of the portfolio, ranked #70.
Adirondack Research & Management first reported a position in MET in Q2 2013 and has held it in 34 quarters since. The position peaked at $681K in Q2 2017. 1,105 funds tracked by Wall St. Rank hold MET as of Q3 2021.
- Adirondack Research & Management held 8,133 shares of MetLife worth $502K as of Q3 2021.
- Adirondack Research & Management sold 330 MetLife shares in Q3 2021, an estimated $19.9K.
- MetLife made up 0.61% of Adirondack Research & Management's portfolio in Q3 2021, its #70 holding.
- Adirondack Research & Management first reported a position in MetLife in Q2 2013 and has held it in 34 quarters since.
- Adirondack Research & Management's MetLife position peaked at $681K in Q2 2017.
- 1,105 funds tracked by Wall St. Rank held MetLife as of Q3 2021.
Based on Adirondack Research & Management's 13F filing for Q3 2021, filed 29 Oct 2021.